PDB Short entry for 4DJY HEADER HYDROLASE/HYDROLASE INHIBITOR 02-FEB-12 4DJY TITLE STRUCTURE OF BACE BOUND TO (R)-5-CYCLOPROPYL-2-IMINO-3-METHYL-5-(3-(5- TITLE 2 (PROP-1-YN-1-YL)PYRIDIN-3-YL)PHENYL)IMIDAZOLIDIN-4-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-SECRETASE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 41-454; COMPND 5 SYNONYM: ASPARTYL PROTEASE 2, ASP2, ASP 2, BETA-SITE AMYLOID COMPND 6 PRECURSOR PROTEIN CLEAVING ENZYME 1, BETA-SITE APP CLEAVING ENZYME 1, COMPND 7 MEMAPSIN-2, MEMBRANE-ASSOCIATED ASPARTIC PROTEASE 2; COMPND 8 EC: 3.4.23.46; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BACE, BACE1, KIAA1149; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET11A KEYWDS BACE1, ALZHEIMERS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.STRICKLAND,J.CUMMING REVDAT 2 04-APR-12 4DJY 1 JRNL REVDAT 1 21-MAR-12 4DJY 0 JRNL AUTH J.N.CUMMING,E.M.SMITH,L.WANG,J.MISIASZEK,J.DURKIN,J.PAN, JRNL AUTH 2 U.ISERLOH,Y.WU,Z.ZHU,C.STRICKLAND,J.VOIGT,X.CHEN, JRNL AUTH 3 M.E.KENNEDY,R.KUVELKAR,L.A.HYDE,K.COX,L.FAVREAU, JRNL AUTH 4 M.F.CZARNIECKI,W.J.GREENLEE,B.A.MCKITTRICK,E.M.PARKER, JRNL AUTH 5 A.W.STAMFORD JRNL TITL STRUCTURE BASED DESIGN OF IMINOHYDANTOIN BACE1 INHIBITORS: JRNL TITL 2 IDENTIFICATION OF AN ORALLY AVAILABLE, CENTRALLY ACTIVE JRNL TITL 3 BACE1 INHIBITOR. JRNL REF BIOORG.MED.CHEM.LETT. V. 22 2444 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22390835 JRNL DOI 10.1016/J.BMCL.2012.02.013 REMARK 2 REMARK 2 RESOLUTION. 1.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 81471 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 4094 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.81 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 6034 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2192 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5714 REMARK 3 BIN R VALUE (WORKING SET) : 0.2160 REMARK 3 BIN FREE R VALUE : 0.2763 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 320 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6112 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 873 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.63020 REMARK 3 B22 (A**2) : -4.27370 REMARK 3 B33 (A**2) : 2.64350 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.12 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6350 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8645 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2129 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 148 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 973 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6350 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 810 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 8206 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 0.97 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.93 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.02 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 28.1739 5.5212 27.8606 REMARK 3 T TENSOR REMARK 3 T11: -0.0104 T22: -0.0074 REMARK 3 T33: -0.0102 T12: -0.0001 REMARK 3 T13: -0.0112 T23: -0.0153 REMARK 3 L TENSOR REMARK 3 L11: 0.3553 L22: 0.1599 REMARK 3 L33: 0.2913 L12: 0.1840 REMARK 3 L13: 0.3271 L23: 0.2397 REMARK 3 S TENSOR REMARK 3 S11: -0.0008 S12: 0.0075 S13: -0.0033 REMARK 3 S21: -0.0077 S22: -0.0112 S23: 0.0233 REMARK 3 S31: -0.0185 S32: -0.0214 S33: 0.0120 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 15.0800 39.5773 62.1450 REMARK 3 T TENSOR REMARK 3 T11: -0.0169 T22: 0.0037 REMARK 3 T33: -0.0180 T12: 0.0001 REMARK 3 T13: 0.0102 T23: 0.0045 REMARK 3 L TENSOR REMARK 3 L11: 0.3605 L22: 0.1620 REMARK 3 L33: 0.3068 L12: 0.1407 REMARK 3 L13: -0.3788 L23: -0.2380 REMARK 3 S TENSOR REMARK 3 S11: -0.0002 S12: -0.0007 S13: 0.0063 REMARK 3 S21: -0.0029 S22: -0.0067 S23: -0.0089 REMARK 3 S31: 0.0019 S32: 0.0144 S33: 0.0069 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4DJY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-FEB-12. REMARK 100 THE RCSB ID CODE IS RCSB070423. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS HTC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 81521 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.860 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.89 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.48100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 43.30650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.53600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.69900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.53600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.30650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.69900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 41 REMARK 465 ARG A 42 REMARK 465 LEU A 43 REMARK 465 PRO A 44 REMARK 465 ARG A 45 REMARK 465 GLU A 46 REMARK 465 THR A 47 REMARK 465 ASP A 48 REMARK 465 GLU A 49 REMARK 465 GLU A 50 REMARK 465 PRO A 51 REMARK 465 GLU A 52 REMARK 465 GLU A 53 REMARK 465 PRO A 54 REMARK 465 GLY A 55 REMARK 465 ARG A 56 REMARK 465 ARG A 57 REMARK 465 PRO A 448 REMARK 465 GLN A 449 REMARK 465 THR A 450 REMARK 465 ASP A 451 REMARK 465 GLU A 452 REMARK 465 SER A 453 REMARK 465 THR A 454 REMARK 465 LEU B 41 REMARK 465 ARG B 42 REMARK 465 LEU B 43 REMARK 465 PRO B 44 REMARK 465 ARG B 45 REMARK 465 GLU B 46 REMARK 465 THR B 47 REMARK 465 ASP B 48 REMARK 465 GLU B 49 REMARK 465 GLU B 50 REMARK 465 PRO B 51 REMARK 465 GLU B 52 REMARK 465 GLU B 53 REMARK 465 PRO B 54 REMARK 465 GLY B 55 REMARK 465 ARG B 56 REMARK 465 ARG B 57 REMARK 465 ILE B 447 REMARK 465 PRO B 448 REMARK 465 GLN B 449 REMARK 465 THR B 450 REMARK 465 ASP B 451 REMARK 465 GLU B 452 REMARK 465 SER B 453 REMARK 465 THR B 454 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 843 O HOH A 927 2.03 REMARK 500 O HOH B 834 O HOH B 878 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 150 64.47 -100.53 REMARK 500 PHE A 169 -60.08 -93.78 REMARK 500 TRP A 258 -81.53 -148.20 REMARK 500 LYS A 299 -59.45 -29.13 REMARK 500 ALA A 333 123.20 -37.83 REMARK 500 THR A 375 32.65 38.94 REMARK 500 SER A 376 -166.95 -62.95 REMARK 500 HIS B 150 52.03 -107.02 REMARK 500 TRP B 258 -81.55 -144.03 REMARK 500 ALA B 333 122.87 -37.36 REMARK 500 SER B 376 -175.64 -63.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 601 DISTANCE = 6.40 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0KR A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TLA A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0KR B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TLA B 502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4DJU RELATED DB: PDB REMARK 900 RELATED ID: 4DJV RELATED DB: PDB REMARK 900 RELATED ID: 4DJW RELATED DB: PDB REMARK 900 RELATED ID: 4DJX RELATED DB: PDB DBREF 4DJY A 41 454 UNP P56817 BACE1_HUMAN 41 454 DBREF 4DJY B 41 454 UNP P56817 BACE1_HUMAN 41 454 SEQRES 1 A 414 LEU ARG LEU PRO ARG GLU THR ASP GLU GLU PRO GLU GLU SEQRES 2 A 414 PRO GLY ARG ARG GLY SER PHE VAL GLU MET VAL ASP ASN SEQRES 3 A 414 LEU ARG GLY LYS SER GLY GLN GLY TYR TYR VAL GLU MET SEQRES 4 A 414 THR VAL GLY SER PRO PRO GLN THR LEU ASN ILE LEU VAL SEQRES 5 A 414 ASP THR GLY SER SER ASN PHE ALA VAL GLY ALA ALA PRO SEQRES 6 A 414 HIS PRO PHE LEU HIS ARG TYR TYR GLN ARG GLN LEU SER SEQRES 7 A 414 SER THR TYR ARG ASP LEU ARG LYS GLY VAL TYR VAL PRO SEQRES 8 A 414 TYR THR GLN GLY LYS TRP GLU GLY GLU LEU GLY THR ASP SEQRES 9 A 414 LEU VAL SER ILE PRO HIS GLY PRO ASN VAL THR VAL ARG SEQRES 10 A 414 ALA ASN ILE ALA ALA ILE THR GLU SER ASP LYS PHE PHE SEQRES 11 A 414 ILE ASN GLY SER ASN TRP GLU GLY ILE LEU GLY LEU ALA SEQRES 12 A 414 TYR ALA GLU ILE ALA ARG PRO ASP ASP SER LEU GLU PRO SEQRES 13 A 414 PHE PHE ASP SER LEU VAL LYS GLN THR HIS VAL PRO ASN SEQRES 14 A 414 LEU PHE SER LEU GLN LEU CYS GLY ALA GLY PHE PRO LEU SEQRES 15 A 414 ASN GLN SER GLU VAL LEU ALA SER VAL GLY GLY SER MET SEQRES 16 A 414 ILE ILE GLY GLY ILE ASP HIS SER LEU TYR THR GLY SER SEQRES 17 A 414 LEU TRP TYR THR PRO ILE ARG ARG GLU TRP TYR TYR GLU SEQRES 18 A 414 VAL ILE ILE VAL ARG VAL GLU ILE ASN GLY GLN ASP LEU SEQRES 19 A 414 LYS MET ASP CYS LYS GLU TYR ASN TYR ASP LYS SER ILE SEQRES 20 A 414 VAL ASP SER GLY THR THR ASN LEU ARG LEU PRO LYS LYS SEQRES 21 A 414 VAL PHE GLU ALA ALA VAL LYS SER ILE LYS ALA ALA SER SEQRES 22 A 414 SER THR GLU LYS PHE PRO ASP GLY PHE TRP LEU GLY GLU SEQRES 23 A 414 GLN LEU VAL CYS TRP GLN ALA GLY THR THR PRO TRP ASN SEQRES 24 A 414 ILE PHE PRO VAL ILE SER LEU TYR LEU MET GLY GLU VAL SEQRES 25 A 414 THR ASN GLN SER PHE ARG ILE THR ILE LEU PRO GLN GLN SEQRES 26 A 414 TYR LEU ARG PRO VAL GLU ASP VAL ALA THR SER GLN ASP SEQRES 27 A 414 ASP CYS TYR LYS PHE ALA ILE SER GLN SER SER THR GLY SEQRES 28 A 414 THR VAL MET GLY ALA VAL ILE MET GLU GLY PHE TYR VAL SEQRES 29 A 414 VAL PHE ASP ARG ALA ARG LYS ARG ILE GLY PHE ALA VAL SEQRES 30 A 414 SER ALA CYS HIS VAL HIS ASP GLU PHE ARG THR ALA ALA SEQRES 31 A 414 VAL GLU GLY PRO PHE VAL THR LEU ASP MET GLU ASP CYS SEQRES 32 A 414 GLY TYR ASN ILE PRO GLN THR ASP GLU SER THR SEQRES 1 B 414 LEU ARG LEU PRO ARG GLU THR ASP GLU GLU PRO GLU GLU SEQRES 2 B 414 PRO GLY ARG ARG GLY SER PHE VAL GLU MET VAL ASP ASN SEQRES 3 B 414 LEU ARG GLY LYS SER GLY GLN GLY TYR TYR VAL GLU MET SEQRES 4 B 414 THR VAL GLY SER PRO PRO GLN THR LEU ASN ILE LEU VAL SEQRES 5 B 414 ASP THR GLY SER SER ASN PHE ALA VAL GLY ALA ALA PRO SEQRES 6 B 414 HIS PRO PHE LEU HIS ARG TYR TYR GLN ARG GLN LEU SER SEQRES 7 B 414 SER THR TYR ARG ASP LEU ARG LYS GLY VAL TYR VAL PRO SEQRES 8 B 414 TYR THR GLN GLY LYS TRP GLU GLY GLU LEU GLY THR ASP SEQRES 9 B 414 LEU VAL SER ILE PRO HIS GLY PRO ASN VAL THR VAL ARG SEQRES 10 B 414 ALA ASN ILE ALA ALA ILE THR GLU SER ASP LYS PHE PHE SEQRES 11 B 414 ILE ASN GLY SER ASN TRP GLU GLY ILE LEU GLY LEU ALA SEQRES 12 B 414 TYR ALA GLU ILE ALA ARG PRO ASP ASP SER LEU GLU PRO SEQRES 13 B 414 PHE PHE ASP SER LEU VAL LYS GLN THR HIS VAL PRO ASN SEQRES 14 B 414 LEU PHE SER LEU GLN LEU CYS GLY ALA GLY PHE PRO LEU SEQRES 15 B 414 ASN GLN SER GLU VAL LEU ALA SER VAL GLY GLY SER MET SEQRES 16 B 414 ILE ILE GLY GLY ILE ASP HIS SER LEU TYR THR GLY SER SEQRES 17 B 414 LEU TRP TYR THR PRO ILE ARG ARG GLU TRP TYR TYR GLU SEQRES 18 B 414 VAL ILE ILE VAL ARG VAL GLU ILE ASN GLY GLN ASP LEU SEQRES 19 B 414 LYS MET ASP CYS LYS GLU TYR ASN TYR ASP LYS SER ILE SEQRES 20 B 414 VAL ASP SER GLY THR THR ASN LEU ARG LEU PRO LYS LYS SEQRES 21 B 414 VAL PHE GLU ALA ALA VAL LYS SER ILE LYS ALA ALA SER SEQRES 22 B 414 SER THR GLU LYS PHE PRO ASP GLY PHE TRP LEU GLY GLU SEQRES 23 B 414 GLN LEU VAL CYS TRP GLN ALA GLY THR THR PRO TRP ASN SEQRES 24 B 414 ILE PHE PRO VAL ILE SER LEU TYR LEU MET GLY GLU VAL SEQRES 25 B 414 THR ASN GLN SER PHE ARG ILE THR ILE LEU PRO GLN GLN SEQRES 26 B 414 TYR LEU ARG PRO VAL GLU ASP VAL ALA THR SER GLN ASP SEQRES 27 B 414 ASP CYS TYR LYS PHE ALA ILE SER GLN SER SER THR GLY SEQRES 28 B 414 THR VAL MET GLY ALA VAL ILE MET GLU GLY PHE TYR VAL SEQRES 29 B 414 VAL PHE ASP ARG ALA ARG LYS ARG ILE GLY PHE ALA VAL SEQRES 30 B 414 SER ALA CYS HIS VAL HIS ASP GLU PHE ARG THR ALA ALA SEQRES 31 B 414 VAL GLU GLY PRO PHE VAL THR LEU ASP MET GLU ASP CYS SEQRES 32 B 414 GLY TYR ASN ILE PRO GLN THR ASP GLU SER THR HET 0KR A 501 26 HET TLA A 502 10 HET 0KR B 501 26 HET TLA B 502 10 HETNAM 0KR (2E,5R)-5-CYCLOPROPYL-2-IMINO-3-METHYL-5-{3-[5-(PROP-1- HETNAM 2 0KR YN-1-YL)PYRIDIN-3-YL]PHENYL}IMIDAZOLIDIN-4-ONE HETNAM TLA L(+)-TARTARIC ACID FORMUL 3 0KR 2(C21 H20 N4 O) FORMUL 4 TLA 2(C4 H6 O6) FORMUL 7 HOH *873(H2 O) HELIX 1 1 GLN A 114 SER A 118 5 5 HELIX 2 2 TYR A 184 ALA A 188 5 5 HELIX 3 3 PRO A 196 THR A 205 1 10 HELIX 4 4 ASN A 223 SER A 230 1 8 HELIX 5 5 ASP A 241 SER A 243 5 3 HELIX 6 6 ASP A 277 TYR A 283 5 7 HELIX 7 7 LYS A 299 SER A 313 1 15 HELIX 8 8 PRO A 319 LEU A 324 1 6 HELIX 9 9 PRO A 337 PHE A 341 5 5 HELIX 10 10 LEU A 362 TYR A 366 1 5 HELIX 11 11 GLY A 395 GLU A 400 1 6 HELIX 12 12 ASP A 439 GLY A 444 5 6 HELIX 13 13 GLN B 114 SER B 118 5 5 HELIX 14 14 TYR B 184 ALA B 188 5 5 HELIX 15 15 PRO B 196 THR B 205 1 10 HELIX 16 16 ASN B 223 SER B 230 1 8 HELIX 17 17 ASP B 241 SER B 243 5 3 HELIX 18 18 ASP B 277 TYR B 283 5 7 HELIX 19 19 LYS B 299 SER B 313 1 15 HELIX 20 20 PRO B 319 LEU B 324 1 6 HELIX 21 21 PRO B 337 PHE B 341 5 5 HELIX 22 22 LEU B 362 TYR B 366 1 5 HELIX 23 23 GLY B 395 GLU B 400 1 6 HELIX 24 24 ASP B 439 GLY B 444 5 6 SHEET 1 A 8 LEU A 67 LYS A 70 0 SHEET 2 A 8 GLY A 74 VAL A 81 -1 O TYR A 76 N ARG A 68 SHEET 3 A 8 GLN A 86 ASP A 93 -1 O VAL A 92 N TYR A 75 SHEET 4 A 8 GLY A 178 GLY A 181 1 O LEU A 180 N LEU A 91 SHEET 5 A 8 PHE A 99 GLY A 102 -1 N ALA A 100 O ILE A 179 SHEET 6 A 8 VAL A 156 ASP A 167 1 O ILE A 163 N VAL A 101 SHEET 7 A 8 LYS A 136 SER A 147 -1 N LYS A 136 O ASP A 167 SHEET 8 A 8 ARG A 122 PRO A 131 -1 N VAL A 130 O TRP A 137 SHEET 1 B 4 LEU A 67 LYS A 70 0 SHEET 2 B 4 GLY A 74 VAL A 81 -1 O TYR A 76 N ARG A 68 SHEET 3 B 4 LYS A 136 SER A 147 -1 O SER A 147 N THR A 80 SHEET 4 B 4 ARG A 122 PRO A 131 -1 N VAL A 130 O TRP A 137 SHEET 1 C 5 GLY A 233 ILE A 237 0 SHEET 2 C 5 PHE A 211 LEU A 215 -1 N GLN A 214 O SER A 234 SHEET 3 C 5 PHE A 402 ASP A 407 -1 O PHE A 406 N PHE A 211 SHEET 4 C 5 ARG A 412 SER A 418 -1 O ALA A 416 N TYR A 403 SHEET 5 C 5 TYR A 245 PRO A 253 -1 N THR A 252 O ILE A 413 SHEET 1 D 5 GLU A 261 VAL A 262 0 SHEET 2 D 5 SER A 286 VAL A 288 -1 O SER A 286 N VAL A 262 SHEET 3 D 5 THR A 392 MET A 394 1 O MET A 394 N ILE A 287 SHEET 4 D 5 LEU A 295 PRO A 298 -1 N ARG A 296 O VAL A 393 SHEET 5 D 5 ILE A 385 SER A 388 1 O SER A 386 N LEU A 297 SHEET 1 E 5 GLN A 272 ASP A 273 0 SHEET 2 E 5 ILE A 264 ILE A 269 -1 N ILE A 269 O GLN A 272 SHEET 3 E 5 ILE A 344 MET A 349 -1 O TYR A 347 N ARG A 266 SHEET 4 E 5 GLN A 355 ILE A 361 -1 O ILE A 361 N ILE A 344 SHEET 5 E 5 ALA A 430 VAL A 436 -1 O GLU A 432 N ARG A 358 SHEET 1 F 3 VAL A 329 TRP A 331 0 SHEET 2 F 3 ASP A 379 PHE A 383 -1 O ASP A 379 N TRP A 331 SHEET 3 F 3 LEU A 367 VAL A 370 -1 N ARG A 368 O LYS A 382 SHEET 1 G 8 LEU B 67 LYS B 70 0 SHEET 2 G 8 GLY B 74 VAL B 81 -1 O TYR B 76 N ARG B 68 SHEET 3 G 8 GLN B 86 ASP B 93 -1 O LEU B 88 N MET B 79 SHEET 4 G 8 GLY B 178 GLY B 181 1 O LEU B 180 N LEU B 91 SHEET 5 G 8 PHE B 99 GLY B 102 -1 N ALA B 100 O ILE B 179 SHEET 6 G 8 VAL B 156 ASP B 167 1 O ILE B 163 N VAL B 101 SHEET 7 G 8 LYS B 136 SER B 147 -1 N LYS B 136 O ASP B 167 SHEET 8 G 8 ARG B 122 PRO B 131 -1 N VAL B 130 O TRP B 137 SHEET 1 H 4 LEU B 67 LYS B 70 0 SHEET 2 H 4 GLY B 74 VAL B 81 -1 O TYR B 76 N ARG B 68 SHEET 3 H 4 LYS B 136 SER B 147 -1 O SER B 147 N THR B 80 SHEET 4 H 4 ARG B 122 PRO B 131 -1 N VAL B 130 O TRP B 137 SHEET 1 I 5 GLY B 233 ILE B 237 0 SHEET 2 I 5 PHE B 211 LEU B 215 -1 N GLN B 214 O SER B 234 SHEET 3 I 5 PHE B 402 ASP B 407 -1 O VAL B 404 N LEU B 213 SHEET 4 I 5 ARG B 412 SER B 418 -1 O ALA B 416 N TYR B 403 SHEET 5 I 5 TYR B 245 PRO B 253 -1 N THR B 252 O ILE B 413 SHEET 1 J 5 GLU B 261 VAL B 262 0 SHEET 2 J 5 SER B 286 VAL B 288 -1 O SER B 286 N VAL B 262 SHEET 3 J 5 THR B 392 MET B 394 1 O MET B 394 N ILE B 287 SHEET 4 J 5 LEU B 295 PRO B 298 -1 N ARG B 296 O VAL B 393 SHEET 5 J 5 ILE B 385 SER B 388 1 O SER B 386 N LEU B 297 SHEET 1 K 5 GLN B 272 ASP B 273 0 SHEET 2 K 5 ILE B 264 ILE B 269 -1 N ILE B 269 O GLN B 272 SHEET 3 K 5 ILE B 344 MET B 349 -1 O TYR B 347 N ARG B 266 SHEET 4 K 5 GLN B 355 ILE B 361 -1 O PHE B 357 N LEU B 348 SHEET 5 K 5 ALA B 430 VAL B 436 -1 O GLU B 432 N ARG B 358 SHEET 1 L 3 VAL B 329 TRP B 331 0 SHEET 2 L 3 ASP B 379 PHE B 383 -1 O TYR B 381 N VAL B 329 SHEET 3 L 3 LEU B 367 VAL B 370 -1 N ARG B 368 O LYS B 382 SSBOND 1 CYS A 216 CYS A 420 1555 1555 2.05 SSBOND 2 CYS A 278 CYS A 443 1555 1555 2.04 SSBOND 3 CYS A 330 CYS A 380 1555 1555 2.05 SSBOND 4 CYS B 216 CYS B 420 1555 1555 2.05 SSBOND 5 CYS B 278 CYS B 443 1555 1555 2.04 SSBOND 6 CYS B 330 CYS B 380 1555 1555 2.04 CISPEP 1 SER A 83 PRO A 84 0 -3.29 CISPEP 2 ARG A 189 PRO A 190 0 2.16 CISPEP 3 TYR A 283 ASP A 284 0 2.34 CISPEP 4 GLY A 433 PRO A 434 0 -4.09 CISPEP 5 SER B 83 PRO B 84 0 -5.16 CISPEP 6 ARG B 189 PRO B 190 0 3.08 CISPEP 7 TYR B 283 ASP B 284 0 0.68 CISPEP 8 GLY B 433 PRO B 434 0 -1.89 SITE 1 AC1 12 SER A 71 GLY A 72 GLN A 73 GLY A 74 SITE 2 AC1 12 ASP A 93 TYR A 132 ILE A 179 ASP A 289 SITE 3 AC1 12 SER A 290 GLY A 291 THR A 292 ALA A 396 SITE 1 AC2 9 ARG A 68 ASN A 89 HIS A 110 ARG A 111 SITE 2 AC2 9 ASN A 175 HOH A 721 HOH A 778 HOH A 793 SITE 3 AC2 9 HOH A 951 SITE 1 AC3 15 SER B 71 GLY B 72 GLN B 73 GLY B 74 SITE 2 AC3 15 ASP B 93 SER B 96 PHE B 169 TRP B 176 SITE 3 AC3 15 ILE B 179 ASP B 289 SER B 290 GLY B 291 SITE 4 AC3 15 THR B 292 ALA B 396 HOH B 991 SITE 1 AC4 9 ARG B 68 ASN B 89 HIS B 110 ARG B 111 SITE 2 AC4 9 ASN B 175 HOH B 704 HOH B 768 HOH B 850 SITE 3 AC4 9 HOH B 856 CRYST1 86.613 89.398 131.072 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011546 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011186 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007629 0.00000